echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > Ann Palliat Med: Ulinastatin can improve the clinical outcome of patients with acute pancreatitis and is related to its dose level

    Ann Palliat Med: Ulinastatin can improve the clinical outcome of patients with acute pancreatitis and is related to its dose level

    • Last Update: 2021-03-18
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Severe acute pancreatitis (SAP) is a serious inflammatory disease with high mortality.


    A retrospective study on the clinical efficacy of 130 SAP patients.


     

    The results showed that the mortality and WBC counts of the 400,000 IU and 600,000 IU groups were significantly lower than those of the 200,000 IU group (P<0.


    In summary, the results of this study show that Ulinastatin can improve the clinical outcome of SAP patients, but the efficacy varies with different doses.


     

    Original source:

     

    Hai Wang He, Hong Zhang.


    ncbi.
    nlm.
    nih.
    gov/32312068/" target="_blank" rel="noopener">The efficacy of different doses of ulinastatin in the treatment of severe acute pancreatitis in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.